Whitehawk Therapeutics, Inc.
WHWK
$1.64
$0.021.24%
| Weiss Ratings | WHWK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | WHWK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | WHWK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.68 | |||
| Price History | WHWK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -3.53% | |||
| 30-Day Total Return | -35.94% | |||
| 60-Day Total Return | -49.38% | |||
| 90-Day Total Return | -29.91% | |||
| Year to Date Total Return | -47.77% | |||
| 1-Year Total Return | -17.59% | |||
| 2-Year Total Return | -78.62% | |||
| 3-Year Total Return | -90.02% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -57.50% | |||
| 52-Week Low % Change | 33.88% | |||
| Price | WHWK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $3.81 | |||
| 52-Week Low Price | $1.21 | |||
| 52-Week Low Price (Date) | Aug 08, 2024 | |||
| 52-Week High Price (Date) | Jan 08, 2025 | |||
| Valuation | WHWK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 75.79M | |||
| Enterprise Value | 29.39M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -2.36 | |||
| Earnings Per Share Growth | -3.57% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 1.69 | |||
| Price/Book (Q) | 0.76 | |||
| Enterprise Value/Revenue (TTM) | 1.13 | |||
| Price | $1.64 | |||
| Enterprise Value/EBITDA (TTM) | -0.45 | |||
| Enterprise Value/EBIT | -0.45 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | WHWK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 27.09M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | WHWK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | -- | |||
| Address | 2 Headquarters Plaza Morristown, NJ 07960 | |||
| Website | ir.whitehawktx.com | |||
| Country | United States | |||
| Year Founded | 2007 | |||
| Profitability | WHWK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -249.47% | |||
| Profit Margin | -245.12% | |||
| Management Effectiveness | WHWK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -39.96% | |||
| Return on Equity | -- | |||
| Income Statement | WHWK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 25.98M | |||
| Total Revenue (TTM) | 25.98M | |||
| Revenue Per Share | $0.96 | |||
| Gross Profit (TTM) | -28.07M | |||
| EBITDA (TTM) | -64.63M | |||
| EBIT (TTM) | -64.82M | |||
| Net Income (TTM) | -63.69M | |||
| Net Income Avl. to Common (TTM) | -63.69M | |||
| Total Revenue Growth (Q YOY) | 14.43% | |||
| Earnings Growth (Q YOY) | -12.32% | |||
| EPS Diluted (TTM) | -2.36 | |||
| EPS Diluted Growth (Q YOY) | -11.82% | |||
| Balance Sheet | WHWK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 47.24M | |||
| Cash Per Share (Q) | $1.74 | |||
| Total Current Assets (Q) | 61.29M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 52.48M | |||
| Current Ratio (Q) | 3.589 | |||
| Book Value Per Share (Q) | $2.13 | |||
| Total Assets (Q) | 70.32M | |||
| Total Current Liabilities (Q) | 17.07M | |||
| Total Debt (Q) | 833.00K | |||
| Total Liabilities (Q) | 17.84M | |||
| Total Common Equity (Q) | 52.48M | |||
| Cash Flow | WHWK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 25.20M | |||
| Cash from Financing (TTM) | 130.00K | |||
| Net Change in Cash (TTM) | -34.22M | |||
| Levered Free Cash Flow (TTM) | -38.69M | |||
| Cash from Operations (TTM) | -59.55M | |||
